T. Nuijens et al. / Tetrahedron Letters 50 (2009) 2719–2721
2721
7. (a) Benoiton, N. L.; Chen, F. M. F. Int. J. Pept. Protein Res. 1994, 43, 321–324; (b)
Belshaw, P. J.; Adamson, J. G.; Lajoie, G. A. Synth. Commun. 1992, 22, 1001–
1005; (c) Baldwin, J. E.; Moloney, M. G.; North, M. Tetrahedron 1989, 45, 6319–
6330; (d) Belshaw, P. J.; Mzengeza, S.; Lajoie, G. A. Synth. Commun. 1990, 20,
3157–3160; (e) Baldwin, J. E.; North, M.; Flinn, A.; Moloney, M. G. Tetrahedron
1989, 45, 1453–1464.
8. (a) Jouln, P.; Castro, B.; Zeggaf, C.; Pantaloni, A. Tetrahedron Lett. 1987, 28,
1665–1668; (b) Cooper, J. W.; Waters, M. L. Org. Lett. 2005, 7, 3825–3828; (c)
Huang, X.; Luo, X.; Roupioz, Y.; Keillor, J. W. J. Org. Chem. 1997, 62, 8821–8825;
(d) Chen, F. M. F.; Benoiton, N. L. Int. J. Pept. Protein Res. 1992, 40, 13–18.
9. Stein, K. A.; Toogood, P. L. J. Org. Chem. 1995, 60, 8110–8112.
10. Xaus, N.; Clapés, P.; Bardaji, E.; Torres, X.; Horba, X.; Mata, J.; Valencia, G.
Tetrahedron 1989, 45, 7421–7426.
11. Obtained from Novozymes, 10 wt % Alcalase solution, 6.75 €/kg (a) Maurer, K.
H. Curr. Opin. Biotechnol. 2004, 15, 330; (b) Smith, E. L.; DeLange, R. J.; Evans, W.
H.; Landon, M.; Markland, F. S. J. Biol. Chem. 1968, 243, 2184; (c) Siezen, R. J.;
Leunissen, J. J. Protein Sci. 1997, 6, 501.
16. (a) Wagner, M.; Kunz, H. Synlett 2000, 3, 400–402; (b) Wagner, M.; Kunz, H. Z.
Naturforsch. 2002, 57b, 928–936.
17. Cbz-Glu(OAll)-OH: 1H NMR (300 MHz, CDCl3) d = 1.94–1.99 (m, 1H), 2.10–2.15
(m, 1H), 2.33–2.39 (m, 2H), 4.24–4.27 (m, 1H), 4.35 (d, J = 6.0 Hz, 2H), 5.01 (s,
2H), 5.13–5.25 (m, 2H), 5.75 (d, J = 7.9 Hz, 1H), 5.74–5.85 (m, 1H), 7.19–7.26
(m, 5H). 13C NMR (75 MHz, CDCl3) d = 27.2, 39.9, 53.4, 65.7, 67.5, 118.7, 128.2,
128.4, 128.7, 132.0, 136.1, 156.4, 177.4, 178.4; Cbz-Asp(OTMSE)-OH: 1H NMR
(300 MHz, CDCl3) d = 0.00 (s, 9H), 0.92–1.01 (m, 2H), 2.85 (dd, J = 4.4 and
17.2 Hz, 1H), 2.90 (dd, J = 4.0 and 16.8 Hz, 1H), 4.18–4.25 (m, 2H), 4.58–4.64
(m, 1H), 5.10 (s, 2H), 5.84 (d, J = 8.1 Hz, 1H), 7.30–7.39 (m, 5H). 13C NMR
(75 MHz, CDCl3) d = À1.5, 17.3, 36.7, 50.4, 53.5, 64.5, 136.2, 159.9, 170.9, 175.4.
18. Cbz-Asp(OAll)-OH: Ginisty, M.; Gravier-Pelletier, C.; Le Merrer, Y. Tetrahedron:
Asymmetry 2006, 17, 142; Boc-Asp(OAll)-OH, Fmoc-Asp(OAll)-OH and Fmoc-
Glu(OAll)-OH: Webster, K. L.; Maude, A. B.; O’Donnell, M. E.; Mehrotra, A. P.;
Gani, D. J. Chem. Soc., Perkin Trans. 1 2001, 1673–1695.
19. Boc-Glu(OAll)-OH: CAS 132286-79-4.
20. Eggen, I.F.; Boeriu, C.G. WO Pat. Appl. No. 2007 082890, CAS No. 147:210280
HCA.
12. Chen, S. T.; Wang, K. T.; Wong, C. H. J. Chem. Soc., Chem. Commun. 1986, 1514–1517.
13. Sheldon, R. A. Biochem. Soc. Trans. 2007, 35, 1583.
21. Alcalase-CLEA (3 g) was added to 0.5 g of Cbz-Asp-OH, 28.0 mL of MTBE, 2.0 mL
of MeOH, and 2.0 g of 3 Å molecular sieves. The mixture was shaken at 50 °C at
150 rpm for 16 h. After filtration, the enzyme was washed thoroughly with
aqueous HCl (pH 1, 3 Â 50 mL) and EtOAc (3 Â 50 mL) followed by filtration.
The combined organic layers were washed with 100 mL of aqueous HCl (pH 1),
dried (Na2SO4), and concentrated in vacuo. The resulting oil was redissolved in
20 mL of CH2Cl2/MeOH/AcOH (89.9:10:0.1) followed by a filtration over silica
gel. The mixture was concentrated in vacuo and dried by co-evaporation with
50 mL of toluene (2Â) and 50 mL of CHCl3 (2Â). The NMR data were identical to
those of the commercially obtained compound.
14. Diallyl ester synthesis of N-protected Asp and Glu; general procedure: 2.0 g of
N-protected amino acid, 2.1 equiv of N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide. HCl (EDCÁHCl), 2.1 equiv of 7-aza-N-hydroxybenzotriazole
(HOAt), and 2.1 equiv of diisopropylethylamine (DIPEA) were dissolved in
100 mL of CH2Cl2 containing 4.0 mL of the appropriate alcohol. The mixture
was stirred at ambient temperature for 24 h and concentrated in vacuo. The
resulting oil was partitioned between 100 mL of EtOAc and 100 mL of saturated
aqueous NaHCO3. The organic phase was washed with 100 mL of saturated
aqueous NaHCO3, 100 mL of aqueous HCl (pH 1, 2Â), 100 mL of brine and
concentrated in vacuo. The resulting oil was purified by preparative HPLC
(using 15% of 0.1 mL/L formic acid in H2O and 85% of 0.1 mL/L formic acid in
acetonitrile as eluent).
22. Cbz-Asp-OMe (281 mg, 1.0 mmol) was dissolved in 50 mL of EtOAc.
Subsequently, 209 mg of EDCÁHCl (1.1 mmol), 192
lL of DIPEA (1.1 mmol),
and 2.0 mL of All-OH were added. The reaction mixture was stirred for 24 h at
rt. The mixture was washed with 50 mL of saturated aqueous NaHCO3, 50 mL
of aqueous HCl (pH 3, 2Â), 50 mL of brine, filtered over basic alumina, dried
(Na2SO4) and concentrated in vacuo. NMR data corresponded to those reported
by: Sears, P.; Schuster, M.; Wang, P.; Witte, K.; Wong, C. H. J. Am. Chem. Soc.
1994, 116, 6521–6530.
15. Enzymatic
a-hydrolysis of diallyl-protected Asp and Glu; general procedure:
3 g of Alcalase-CLEA (purchased from Codexis (Jülich, Germany) and used as
received) was added to 0.5 g of diallyl-protected amino acid, 15.0 mL of tBuOH
or 1,4-dioxane, and 15.0 mL of phosphate buffer (pH 7.5, 50 mM). The mixture
was shaken at 37 °C at 200 rpm for 16 h. After filtration, the enzyme was re-
suspended in 50 mL of saturated aqueous NaHCO3 followed by filtration. This
procedure was repeated twice with saturated aqueous NaHCO3 and twice with
50 mL of EtOAc. The combined organic phase was washed with saturated
aqueous NaHCO3. The combined aqueous phase was acidified to pH 1 with
aqueous HCl (0.1 N) followed by extraction with 100 mL of EtOAc (3Â). The
combined organic layers were washed with 250 mL of brine, dried over
Na2SO4, concentrated in vacuo, and dried by co-evaporation with 50 mL of
toluene (2Â) and 50 mL of CHCl3 (2Â). Additional column chromatography
with EtOAc/n-hexane mixtures was performed if necessary. The purity of the b-
23. Cbz-Asp-OMe (281 mg, 1.0 mmol) was dissolved in 60 mL of CH3CN/tBuOH (2/
1, v/v). Subsequently, 218 mg of Boc2O (1.0 mmol), 81 lL of pyridine
(1.0 mmol), and 5 mg of (N,N)-dimethylaminopyridine were added. The
reaction mixture was stirred at rt for 24 h and concentrated in vacuo. The
residue was dissolved in 50 mL of EtOAc and washed with 50 mL of saturated
aqueous NaHCO3, 50 mL of aqueous HCl (pH 3, 2Â), 50 mL of brine, filtered
over basic alumina, dried (Na2SO4) and concentrated in vacuo. NMR data
corresponded to those reported by David, C.; Bischoff, L.; Roques, B. P.; Fournie-
Zaluski, M. C. Tetrahedron 1999, 56, 209–215.
or
c
-ester of the N-protected Asp or Glu derivatives, respectively, was >98% as
24. NMR data corresponded with the commercially available reference compound,
determined by HPLC.
Cbz-Asp(OtBu)-OH: CAS. 5545-52-8.